Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Are You Handling Big Data & Innovation?

Posted on April 28th, 2017 by in Pharma R&D

Although every pharmaceutical company still hopes to find the next blockbuster drug, today’s R&D departments are becoming increasingly focused on developing more targeted therapies. It is the advent of Big Data that has made it possible for researchers to advance precision medicine and targeted drugs Continue reading “How Are You Handling Big Data & Innovation?” »

Organizational Evolution: Balancing Exploration & Development

Posted on April 26th, 2017 by in Pharma R&D

Rubius Therapeutics had an extraordinary 2016. We were able to dramatically progress our work on the technology platform (where we expanded the number of different ways that we can express proteins) Continue reading “Organizational Evolution: Balancing Exploration & Development” »

Making Precision Medicine a Reality

Posted on April 24th, 2017 by in Chemistry

Precision medicine is no longer just a promising new development discussed only by medical professionals and industry insiders at conferences and in journals. In early 2015, former U.S. President Barack Obama announced the $215 million Precision Medicine Initiative Continue reading “Making Precision Medicine a Reality” »

Assessing Our Progress and Looking Ahead

Posted on April 21st, 2017 by in The Hive

Like many start-ups, Reset Therapeutics has been driven by big ideas, which we have pursued with passion, commitment and accountability. Continue reading “Assessing Our Progress and Looking Ahead” »

  1. 1
  2. 2
  3. 3